Cargando…
21P COVID-19 cancer patients and thromboembolic disease: Survival analysis
Autores principales: | Pertejo-Fernandez, A., Martínez-Recio, S., Jiménez-Bou, D., Peña-López, J., Ruiz-Gutiérrez, I., Martín-Montalvo Pérez, G., Rueda-Lara, A., Martínez-Marín, V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503655/ http://dx.doi.org/10.1016/j.annonc.2021.08.2017 |
Ejemplares similares
-
1582P Thromboembolic disease in COVID-19 cancer patients: Impact on overall survival and prognostic factors
por: Pertejo, A., et al.
Publicado: (2021) -
Clinical Score to Predict Recurrence in Patients with Stage II and Stage III Colon Cancer
por: Viñal, David, et al.
Publicado: (2022) -
PO-21 Incidence of venous thromboembolism events in outpatients with cancer and COVID-19.
por: Gutiérrez Ortiz de la Tabla, A., et al.
Publicado: (2021) -
Clinico-Pathological Features, Outcomes and Impacts of COVID-19 Pandemic on Patients with Early-Onset Colorectal Cancer: A Single-Institution Experience
por: Martinez-Perez, Daniel, et al.
Publicado: (2023) -
Direct oral anticoagulants for the treatment and prevention of venous thromboembolism in patients with cancer: current evidence
por: García-Escobar, I., et al.
Publicado: (2020)